Editing
Stones: Diet and Pharmacologic Management
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Uric acid stones=== ==== Potassium citrate ==== *'''<span style="color:#ff0000">First-line therapy for patients with uric acid stones</span>''' *'''<span style="color:#ff0000">Goal is to alkalinize (increase the pH) of the urine to an optimal level (pH > 5.5 (AUA targets 6.0 and CUA targets 6.5)) so that uric acid remains in a dissolved state</span>''' **'''Attempts at alkalinizing the urine to a pH > 7.0 should be avoided. At a higher pH, there is a danger of increasing the risk for calcium phosphate stone formation.''' *Patients may initially present with low/normal 24-hour urinary uric acid levels because the uric acid will precipitate out of solution in the acid urinary environment. Once the urine has been alkalized, all of the uric acid will come back into solution, causing a significant increase in the measured urinary uric acid. ==== Allopurinol ==== *'''<span style="color:#ff0000">Should not be routinely offered as first-line therapy to patients with uric acid stones</span>''' **'''Most patients with uric acid stones have low urinary pH rather than hyperuricosuria as the predominant risk factor''' *'''<span style="color:#ff0000">May be considered as an adjunct when alkalinization is not successful or for patients who continue to form uric acid stones despite adequate alkalinization of the urine.</span>''' *'''Dosage: allopurinol 300 mg/day may be used''' **MOA: blocks the ability of xanthine oxidase to convert xanthine to uric acid, resulting in decreased production of uric acid ***The resultant decrease in serum uric acid will ultimately lead to a decrease in urinary uric acid as well. ==== Acetazolamide ==== *'''Effective in increasing the urinary pH in patients with uric acid and cystine stone formation who are already taking potassium citrate.''' **Acetazolamide, a carbonic anhydrase inhibitor, leads to an increase in urinary bicarbonate and increased H+ reabsorption. **Up to 50% of patients may discontinue acetazolamide due to adverse effects.
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information